Campylobacter lari

Campylobacter laridis
Scientific classification
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Epsilon Proteobacteria
Order: Campylobacterales
Family: Campylobacteraceae
Genus: Campylobacter
Species: C. laridis
Binomial name
Campylobacter laridis
Benjamin et al., 1984
Subspecies

C. lari subsp. concheus
Debruyne et al. 2009
C. lari subsp. lari
(Benjamin et al. 1984)
Debruyne et al. 2009

Campylobacter lari (formerly Campylobacter laridis[1]) is a species of nalidixic acid-resistant, thermophilic, microaerophilic bacteria first isolated from human faeces.[2][3] It shows anaerobic growth in the presence of trimethylamine N-oxide hydrochloride. Its type strain is NCTC 11352. It is commonly found in sea gulls. In humans, it has been involved in cases of enteritis,[4] severe abdominal pain and terminal bacteremia.[5][6]

See also

References

  1. ↑ von Graevenitz, A. (April 1990). "Revised nomenclature of Campylobacter laridis, Enterobacter intermedium, and "Flavobacterium branchiophila"". International Journal of Systematic Bacteriology 40 (2): 211. doi:10.1099/00207713-40-2-211. PMID 2223613. Retrieved 8 November 2014.
  2. ↑ Benjamin, J.; Leaper, S.; Owen, R. J.; Skirrow, M. B. (1983). "Description ofCampylobacter laridis, a new species comprising the nalidixic acid resistant thermophilicCampylobacter (NARTC) group". Current Microbiology 8 (4): 231–238. doi:10.1007/BF01579552. ISSN 0343-8651.
  3. ↑ Nachamkin, I. (1992). "Identification of Campylobacter laridis". Clinical Infectious Diseases 15 (6): 1055–1055. doi:10.1093/clind/15.6.1055. ISSN 1058-4838.
  4. ↑ Simor AE, Wilcox L (1987). "Enteritis associated with Campylobacter laridis.". J Clin Microbiol 25 (1): 10–2. PMC 265800. PMID 3793864.
  5. ↑ Tauxe RV, Patton CM, Edmonds P, Barrett TJ, Brenner DJ, Blake PA (1985). "Illness associated with Campylobacter laridis, a newly recognized Campylobacter species.". J Clin Microbiol 21 (2): 222–5. PMC 271617. PMID 3972989.
  6. ↑ Nachamkin, Irving (1984). "Campylobacter laridis Causing Bacteremia in an Immunosuppressed Patient". Annals of Internal Medicine 101 (1): 55. doi:10.7326/0003-4819-101-1-55. ISSN 0003-4819.